BIRC5 and prostate carcinoma: Prostate cancer cells treated with the respective growth inhibitory IC25 and IC50 drug concentrations of APX3330 and APX2009 (as determined in Table 1) exhibited a significant decrease in survivin protein expression within 48 hours compared to DMSO treated controls (Figure 3A–3D).